SyriMed recalls Baclofen oral solution due to crystallisation issues
Syri Limited is recalling Baclofen 10mg/5ml oral solution due to crystallisation observed over time.
Asset / Drug
Drug and asset intelligence for Baclofen with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.